You have no items in your shopping cart.
Description
Research Area
Images & Validation
−| Application Notes |
|---|
Key Properties
−| Expression System | HEK293 |
|---|---|
| Target | OX40 |
| Reactivity | Mouse |
| Tag | C-Fc |
| Expression Region | Val 20 - Pro 211 |
| Endotoxins | 1.0 EU per μg |
| Conjugation | Unconjugated |
| MW | 47.9 kDa |
| Purity | 90% |
Storage & Handling
−| Storage | -20°C |
|---|---|
| Form/Appearance | Powder |
| Buffer/Preservatives | Tris with Glycine, Arginine and NaCl, pH 7.5 |
| Expiration Date | 6 months from date of receipt. |
| Disclaimer | For research use only |
Similar Products
−Recombinant Mouse OX40 Protein [orb2994427]
Unconjugated
Predicted: 47.4 KDa. Observed: 55-88 KDa, reducing conditions
50 μg, 500 μg, 1 mg, 10 μgRecombinant Mouse OX40 Protein [orb2994428]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 48.4 KDa. Observed: 65-90 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mgRecombinant Mouse OX40L Protein [orb2992812]
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE. (QC verified)
Predicted: 45.7 KDa. Observed: 50-68 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mgRecombinant Human OX40 Protein [orb2994049]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 46.8 KDa. Observed: 65-80 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mgRecombinant Human OX40L Protein [orb2994050]
Unconjugated
Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 42.2 KDa. Observed: 50-70 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg

Quality Guarantee
Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

